Edited by Charles E. SamuelThe viral restriction factor SERINC5 inhibits HIV-1 infection via unknown mechanisms. Sood and co-workers now show that SERINC5 suppresses HIV-1 fusogenicity and increases sensitivity to neutralizing antibodies by perturbing the folding of the fusion machinery. This work advances our understanding of host-virus interactions and provides a compelling case for considering the host immune system in studies of restriction factor mechanisms.Despite the enormous impact of the HIV-1 pandemic on human health and the intense scrutiny to which the virus has been subjected, many facets of HIV-1 biology have eluded comprehensive explanation for many years. Among these are viral accessory proteins, which have evolved to circumvent host factors that restrict retroviral infection. Perhaps the most enigmatic of these HIV-1 accessory proteins is Nef. Nef is known to interact with and regulate a myriad of host proteins and processes and has long been known to enhance viral infectivity (1). However, unlike other HIV-1 accessory proteins, none of the well-studied functions of Nef appeared to explain the enhanced viral infectivity, suggesting that an as-yet-unidentified host factor must inhibit HIV-1 infectivity and, in turn, be countered by Nef.In 2015, back-to-back publications revealed the identities of the Nef-targeted host factors to be SERINC5 (serine incorporator 5) and SERINC3 (2, 3); the SERINC proteins are multipass membrane-spanning proteins, of which little is known beyond a role in the synthesis of serine-containing lipids. Of the five SERINC proteins, only SERINC3 and SERINC5 have activity against HIV-1, and SERINC5 is significantly more potent. These papers, and others that followed, quickly established the importance of SERINC5 as a genuine viral restriction factor. For example, where Nef is absent, retroviruses have independently evolved proteins to counter SERINC5 activity, such as glycoGag of murine leukemia virus (2, 3) and the S2 accessory protein of equine infectious anemia virus (4). Furthermore, a study of primate lentiviruses in the wild revealed a correlation between their prevalence in the susceptible population and the ability to antagonize SERINC5 (5). We have since learned that Nef counters SERINC5 by preventing its incorporation into virions. In the absence of Nef, SERINC5 packages into virions and appears to inhibit viral fusion at a post-receptorbinding step; however, the mechanism by which SERINC5 impairs fusion is not clear, and there is a significantly greater impact on viral infectivity than on fusion (2, 3). Intriguingly, it has been reported that many primary isolates of HIV-1 are resistant to this fusion-defect and that resistance is conferred by the envelope glycoprotein (Env) in the viral membrane (6). This protein binds to receptors on the target cell and mediates fusion between the virus and host membranes. Primary isolates were not entirely impervious to the effects of SERINC5, however, as they exhibited increased sensitivity to neutralizing antisera (6). Thus, ...